139 related articles for article (PubMed ID: 8314205)
1. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma.
Rieu M; Rosilio M; Richard A; Vannetzel JM; Kuhn JM
Horm Res; 1993; 39(5-6):207-12. PubMed ID: 8314205
[TBL] [Abstract][Full Text] [Related]
2. Ectopic Cushing's syndrome: Paradoxical effect of somatostatin analogs.
Biagetti B; Simó-Servat O; Ortiz-Z A; Iglesias C; Mesa J
Endocrinol Diabetes Nutr; 2017 May; 64(5):276-278. PubMed ID: 29056252
[No Abstract] [Full Text] [Related]
3. Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer.
Shepherd FA; Laskey J; Evans WK; Goss PE; Johansen E; Khamsi F
J Clin Oncol; 1992 Jan; 10(1):21-7. PubMed ID: 1309381
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for somatostatin and its analogs in Cushing's syndrome?
de Herder WW; Lamberts SW
Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline plus lanreotide for ectopic Cushing's syndrome.
Pivonello R; Ferone D; Lamberts SW; Colao A
N Engl J Med; 2005 Jun; 352(23):2457-8. PubMed ID: 15944436
[No Abstract] [Full Text] [Related]
6. Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment.
Falhammar H
N Z Med J; 2009 Apr; 122(1294):92-5. PubMed ID: 19465952
[TBL] [Abstract][Full Text] [Related]
7. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effect of octreotide in neoplastic inappropriate corticotropin secretion.
Duquenne M; Dousset B; Weryha G; Fade-Schneller O; Duriez T; Anthoine D; Leclere J; Hartemann P
Lancet; 1991 Nov; 338(8779):1407-8. PubMed ID: 1682776
[No Abstract] [Full Text] [Related]
9. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.
De Rosa G; Testa A; Liberale I; Pirronti T; Granone P; Picciocchi A
Exp Clin Endocrinol; 1993; 101(5):319-25. PubMed ID: 8299710
[TBL] [Abstract][Full Text] [Related]
10. Long-acting formulations of somatostatin analogues.
Anthony LB
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S216-8. PubMed ID: 10604134
[TBL] [Abstract][Full Text] [Related]
11. Small cell carcinoma of the vagina causing Cushing's syndrome by ectopic production and secretion of ACTH: a case report.
Colleran KM; Burge MR; Crooks LA; Dorin RI
Gynecol Oncol; 1997 Jun; 65(3):526-9. PubMed ID: 9190988
[TBL] [Abstract][Full Text] [Related]
12. Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.
Ruszniewski P; Girard F; Benamouzig R; Mignon M; Bonfils S
Gut; 1988 Jun; 29(6):838-42. PubMed ID: 2898423
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogs in ectopic corticotropin production.
von Werder K; Muller OA; Stalla GK
Metabolism; 1996 Aug; 45(8 Suppl 1):129-31. PubMed ID: 8769407
[TBL] [Abstract][Full Text] [Related]
14. [Hypokalemia from ectopic ACTH secretion and hypothiroidism in patient affected by small cell lung cancer].
Bindi M; Moruzzo D; Pinelli M; Rosada J; Castiglioni M
Recenti Prog Med; 2009 Mar; 100(3):137-9. PubMed ID: 19475841
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
de Herder WW; Krenning EP; Malchoff CD; Hofland LJ; Reubi JC; Kwekkeboom DJ; Oei HY; Pols HA; Bruining HA; Nobels FR
Am J Med; 1994 Apr; 96(4):305-12. PubMed ID: 8166148
[TBL] [Abstract][Full Text] [Related]
16. Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?
Uwaifo GI; Koch CA; Hirshberg B; Chen CC; Hartzband P; Nieman LK; Pacak K
J Endocrinol Invest; 2003 Aug; 26(8):710-7. PubMed ID: 14669823
[TBL] [Abstract][Full Text] [Related]
17. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide.
Van den Bruel A; Bex M; Van Dorpe J; Heyns W; Bouillon R
Clin Endocrinol (Oxf); 1998 Oct; 49(4):541-6. PubMed ID: 9876354
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).
Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F
Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871
[TBL] [Abstract][Full Text] [Related]
19. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
20. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin).
Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ
Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
